Company News: Johnson & Johnson (JNJ) Q1 EPS beat analysts’ estimate

Market news

18 April 2017

Company News: Johnson & Johnson (JNJ) Q1 EPS beat analysts’ estimate

Johnson & Johnson reported Q1 FY 2017 earnings of $1.83 per share (versus $1.68 in Q1 FY 2016), beating analysts' consensus estimate of $1.77.

The company's quarterly revenues amounted to $17.766 bln (+1.6% y/y), missing analysts' consensus estimate of $18.020 bln.

The company also issued guidance for FY 2017, projecting EPS of $7.00-7.15 versus analysts' consensus estimate of $7.08 and revenues of $75.4-76.1 bln versus analysts' consensus estimate of $75.21 bln.

JNJ fell to $124.20 (-1.21%) in pre-market trading.

U.S.: Building Permits, March 1260 (forecast 1250)

Saudi govt will only tap reserves if needed, otherwise will cover deficit using markets - Minister

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.